GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sagimet Biosciences Inc (FRA:0O2) » Definitions » 6-1 Month Momentum %

Sagimet Biosciences (FRA:0O2) 6-1 Month Momentum % : 7.18% (As of Jun. 03, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sagimet Biosciences 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-06-03), Sagimet Biosciences's 6-1 Month Momentum % is 7.18%.

The industry rank for Sagimet Biosciences's 6-1 Month Momentum % or its related term are showing as below:

FRA:0O2's 6-1 Month Momentum % is ranked better than
57.02% of 1524 companies
in the Biotechnology industry
Industry Median: -4.805 vs FRA:0O2: 7.18

Competitive Comparison of Sagimet Biosciences's 6-1 Month Momentum %

For the Biotechnology subindustry, Sagimet Biosciences's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sagimet Biosciences's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sagimet Biosciences's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Sagimet Biosciences's 6-1 Month Momentum % falls into.



Sagimet Biosciences  (FRA:0O2) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sagimet Biosciences  (FRA:0O2) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Sagimet Biosciences 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Sagimet Biosciences's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sagimet Biosciences (FRA:0O2) Business Description

Traded in Other Exchanges
Address
155 Bovet Road, Suite 303, San Mateo, CA, USA, 94402
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

Sagimet Biosciences (FRA:0O2) Headlines

No Headlines